Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2430958
Max Phase: Preclinical
Molecular Formula: C25H21ClN4O2
Molecular Weight: 444.92
Molecule Type: Small molecule
Associated Items:
ID: ALA2430958
Max Phase: Preclinical
Molecular Formula: C25H21ClN4O2
Molecular Weight: 444.92
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nn(C)c(Cl)c1/C=C/C(=O)/C=C/c1ccc(Oc2ncnc3c(C)cccc23)cc1
Standard InChI: InChI=1S/C25H21ClN4O2/c1-16-5-4-6-22-23(16)27-15-28-25(22)32-20-12-8-18(9-13-20)7-10-19(31)11-14-21-17(2)29-30(3)24(21)26/h4-15H,1-3H3/b10-7+,14-11+
Standard InChI Key: BWPMHIJHGUCQJN-APBFJCRLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 444.92 | Molecular Weight (Monoisotopic): 444.1353 | AlogP: 5.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 69.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 2.60 | CX LogP: 5.76 | CX LogD: 5.76 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.36 | Np Likeness Score: -1.10 |
1. Luo H, Yang S, Zhao Q, Xiang H. (2013) Synthesis and antitumor properties of novel curcumin analogs, [10.1007/s00044-013-0854-3] |
Source(1):